Whitehawk Therapeutics Stock Volatility
| WHWK Stock | 2.85 0.16 5.32% |
Whitehawk Therapeutics appears to be risky, given 3 months investment horizon. Whitehawk Therapeutics shows Sharpe Ratio of 0.14, which attests that the company had a 0.14 % return per unit of risk over the last 3 months. By examining Whitehawk Therapeutics' technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please utilize Whitehawk Therapeutics' Mean Deviation of 3.32, market risk adjusted performance of 0.623, and Downside Deviation of 3.75 to validate if our risk estimates are consistent with your expectations.
Sharpe Ratio = 0.1419
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | WHWK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Whitehawk Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Whitehawk Therapeutics by adding it to a well-diversified portfolio.
Key indicators related to Whitehawk Therapeutics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Whitehawk Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Whitehawk daily returns, and it is calculated using variance and standard deviation. We also use Whitehawk's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Whitehawk Therapeutics volatility.
Whitehawk | Build AI portfolio with Whitehawk Stock |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Whitehawk Therapeutics at lower prices. For example, an investor can purchase Whitehawk stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes. Main indicators related to Whitehawk Therapeutics' market risk premium analysis include:
Beta 0.79 | Alpha 0.43 | Risk 4.27 | Sharpe Ratio 0.14 | Expected Return 0.61 |
Moving together with Whitehawk Stock
| 0.77 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.72 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.62 | EQ | Equillium | PairCorr |
| 0.61 | VALN | Valneva SE ADR | PairCorr |
| 0.62 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.74 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.66 | VERA | Vera Therapeutics Sell-off Trend | PairCorr |
| 0.67 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.89 | DRTS | Alpha Tau Medical | PairCorr |
| 0.78 | DSGN | Design Therapeutics | PairCorr |
Moving against Whitehawk Stock
| 0.79 | OSE | OSE Pharma SA | PairCorr |
| 0.7 | DRMA | Dermata Therapeutics | PairCorr |
| 0.63 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.51 | VCEL | Vericel Corp Ord | PairCorr |
| 0.49 | ABNX | Abionyx Pharma SA | PairCorr |
| 0.45 | VCYT | Veracyte | PairCorr |
| 0.31 | CDIOW | Cardio Diagnostics | PairCorr |
Whitehawk Therapeutics Market Sensitivity And Downside Risk
Whitehawk Therapeutics' beta coefficient measures the volatility of Whitehawk stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Whitehawk stock's returns against your selected market. In other words, Whitehawk Therapeutics's beta of 0.79 provides an investor with an approximation of how much risk Whitehawk Therapeutics stock can potentially add to one of your existing portfolios. Whitehawk Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Whitehawk Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Whitehawk Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
| α | 0.43 | β | 0.79 | Check current 90 days Whitehawk Therapeutics correlation with market (Dow Jones Industrial)
Whitehawk Therapeutics Volatility and Downside Risk
Whitehawk standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Using Whitehawk Put Option to Manage Risk
Put options written on Whitehawk Therapeutics grant holders of the option the right to sell a specified amount of Whitehawk Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Whitehawk Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Whitehawk Therapeutics' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Whitehawk Therapeutics will be realized, the loss incurred will be offset by the profits made with the option trade.
Whitehawk Therapeutics' PUT expiring on 2026-04-17
Profit |
| Whitehawk Therapeutics Price At Expiration |
Whitehawk Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Whitehawk Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Whitehawk Therapeutics' price changes. Investors will then calculate the volatility of Whitehawk Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Whitehawk Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Whitehawk Therapeutics' fluctuations based on previous trends. It's commonly used to predict Whitehawk Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Whitehawk Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Whitehawk Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Whitehawk Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Whitehawk Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days Whitehawk Therapeutics has a beta of 0.786 . This entails as returns on the market go up, Whitehawk Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Whitehawk Therapeutics will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Whitehawk Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Whitehawk Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Whitehawk stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives a Whitehawk Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Whitehawk Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Whitehawk Therapeutics is 704.69. The daily returns are distributed with a variance of 18.25 and standard deviation of 4.27. The mean deviation of Whitehawk Therapeutics is currently at 3.4. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.81
α | Alpha over Dow Jones | 0.43 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 4.27 | |
Ir | Information ratio | 0.10 |
Whitehawk Therapeutics Stock Return Volatility
Whitehawk Therapeutics historical daily return volatility represents how much of Whitehawk Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 4.2725% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7615% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Whitehawk Stock performing well and Whitehawk Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Whitehawk Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CLNN | 4.95 | (1.17) | 0.00 | (0.55) | 0.00 | 9.44 | 38.74 | |||
| MGNX | 2.87 | 0.33 | 0.09 | 1.52 | 2.96 | 6.83 | 24.44 | |||
| IMMX | 4.82 | 1.34 | 0.32 | 1.08 | 3.74 | 14.88 | 28.79 | |||
| TVGN | 4.56 | (0.78) | 0.00 | (0.33) | 0.00 | 10.00 | 26.81 | |||
| OVID | 4.41 | 0.09 | 0.03 | 0.10 | 4.99 | 9.70 | 36.13 | |||
| ZNTL | 5.13 | 1.09 | 0.21 | 0.57 | 4.58 | 17.36 | 49.29 | |||
| CNTX | 4.24 | 1.12 | 0.24 | (11.65) | 3.60 | 9.59 | 24.11 | |||
| ONCY | 4.15 | 0.03 | 0.02 | 0.08 | 4.37 | 12.64 | 27.46 | |||
| PLRX | 2.53 | (0.60) | 0.00 | (0.36) | 0.00 | 4.59 | 22.72 | |||
| ATOS | 3.90 | (1.49) | 0.00 | (1.69) | 0.00 | 6.75 | 42.59 |
About Whitehawk Therapeutics Volatility
Volatility is a rate at which the price of Whitehawk Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Whitehawk Therapeutics may increase or decrease. In other words, similar to Whitehawk's beta indicator, it measures the risk of Whitehawk Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Whitehawk Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 63.5 M | 60.3 M |
Whitehawk Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Whitehawk Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Whitehawk Therapeutics' price varies over time.
3 ways to utilize Whitehawk Therapeutics' volatility to invest better
Higher Whitehawk Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Whitehawk Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Whitehawk Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Whitehawk Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Whitehawk Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Whitehawk Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Whitehawk Therapeutics Investment Opportunity
Whitehawk Therapeutics has a volatility of 4.27 and is 5.62 times more volatile than Dow Jones Industrial. 38 percent of all equities and portfolios are less risky than Whitehawk Therapeutics. You can use Whitehawk Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Whitehawk Therapeutics to be traded at 2.71 in 90 days.Very poor diversification
The correlation between Whitehawk Therapeutics and DJI is 0.87 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Whitehawk Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Whitehawk Therapeutics Additional Risk Indicators
The analysis of Whitehawk Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Whitehawk Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Whitehawk Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1028 | |||
| Market Risk Adjusted Performance | 0.623 | |||
| Mean Deviation | 3.32 | |||
| Semi Deviation | 3.44 | |||
| Downside Deviation | 3.75 | |||
| Coefficient Of Variation | 851.82 | |||
| Standard Deviation | 4.19 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Whitehawk Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Whitehawk Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Whitehawk Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Whitehawk Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Whitehawk Therapeutics.
When determining whether Whitehawk Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Whitehawk Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Whitehawk Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Whitehawk Therapeutics Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Whitehawk Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. For more information on how to buy Whitehawk Stock please use our How to buy in Whitehawk Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Whitehawk Therapeutics. Anticipated expansion of Whitehawk directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Whitehawk Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.64) | Revenue Per Share | Quarterly Revenue Growth 0.335 | Return On Assets | Return On Equity |
Investors evaluate Whitehawk Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Whitehawk Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Whitehawk Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Whitehawk Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Whitehawk Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Whitehawk Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.